PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
6.32%
Net income growth under 50% of CRON.TO's 55.88%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-2.20%
Both reduce yoy D&A, with CRON.TO at -1.04%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-1825.75%
Negative yoy deferred tax while CRON.TO stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
19.04%
SBC growth while CRON.TO is negative at -8.43%. John Neff would see competitor possibly controlling share issuance more tightly.
204.53%
Well above CRON.TO's 89.17% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
418.06%
AR growth while CRON.TO is negative at -70.47%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
2375.00%
Inventory growth well above CRON.TO's 93.63%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
169.71%
A yoy AP increase while CRON.TO is negative at -359.36%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
177.58%
Growth well above CRON.TO's 94.69%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-30.49%
Both negative yoy, with CRON.TO at -156.38%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
163.13%
Operating cash flow growth above 1.5x CRON.TO's 75.31%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
-51.23%
Negative yoy CapEx while CRON.TO is 37.56%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
-1765.89%
Negative yoy acquisition while CRON.TO stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-63.73%
Both yoy lines negative, with CRON.TO at -17.63%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-17557.64%
We reduce yoy invests while CRON.TO stands at 101.60%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-771.10%
We cut debt repayment yoy while CRON.TO is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-102.24%
Negative yoy issuance while CRON.TO is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
102.24%
Similar buyback growth to CRON.TO's 94.86%. Walter Schloss sees parallel capital return priorities or a stable free cash flow for both.